Schwab U.S. Small-Cap ETF (NY:SCHA)

33.31 +0.07 (+0.21%)

Delayed Quote Updated: 9:55 AM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Schwab U.S. Small-Cap ETF

< Previous 1 2 Next >

Schwab Small-Cap ETF Outperforms Vanguard on One-Year Returns by Letting Sandisk Shine ↗

September 01, 2026

Both funds charge identical 0.03% expense ratios, but Vanguard holds significantly more assets and offers a higher dividend yield of 1.2%.

Via The Motley Fool

Topics ETFs Stocks

ISCB vs. SCHA: Which Small-Cap ETF Should You Buy in 2026? ↗

July 16, 2026

SCHA has outperformed over the last year, but ISCB offers a higher dividend yield and industrial exposure.

Via The Motley Fool

Topics ETFs

VB vs. SCHA: Which Small-Cap ETF Is the Better Buy for Investors? ↗

July 15, 2026

Both offer exceptionally low expense ratios of 0.03%, but SCHA has delivered a stronger one-year return.

Via The Motley Fool

Topics ETFs Stocks

Which Is the Better Small-Cap ETF, Schwab's SCHA or iShares' IJR? ↗

July 11, 2026

SCHA tracks 1,727 stocks with a tech tilt and half IJR's fees. IJR takes a more selective approach with 652 holdings focused on profitability.

Via The Motley Fool

Topics ETFs

SCHA vs. SPSM: Which Small-Cap ETF Is the Better Buy? ↗

July 07, 2026

SCHA's broader portfolio delivered stronger one-year returns, while SPSM offers a higher dividend yield and lower volatility.

Via The Motley Fool

Topics ETFs Stocks

SCHA vs. ISCB: Which Small-Cap ETF Is the Better Buy for Investors in 2026? ↗

June 17, 2026

Sector allocations, expense ratios, and yield profiles set these two small-cap ETFs apart for investors seeking portfolio diversification.

Via The Motley Fool

Topics ETFs Stocks

Schwab (SCHA) vs. iShares (IJR): Which Small Cap ETF Should Investors Buy? ↗

June 10, 2026

Expense ratios, sector weights, and risk profiles set these two small-cap ETFs apart for investors seeking growth and diversification.

Via The Motley Fool

Topics ETFs

Small-Cap ETF Showdown: Schwab's SCHA vs. iShares' IJR ↗

May 11, 2026

Expense ratios, diversification, and sector tilts set these two small-cap ETFs apart. Explore how their strategies impact risk and long-term performance.

Via The Motley Fool

Topics ETFs

Vanguard vs. Schwab: Which Small-Cap ETF Belongs in Your Portfolio? ↗

April 29, 2026

Expense ratios, diversification, and recent returns reveal key differences between these two leading small-cap ETFs.

Via The Motley Fool

Topics ETFs Stocks

Schwab Small Cap ETF Tops State Street in Returns and Diversification ↗

April 29, 2026

Compare how expense ratios, yield, and portfolio breadth set these two small-cap ETFs apart in risk and income profile.

Via The Motley Fool

Topics ETFs Stocks

SCHA vs. ISCB Comes Down to Sector Tilt and Your Drawdown Tolerance ↗

April 24, 2026

Compare how sector focus, fund size, and portfolio makeup set these two low-cost small-cap ETFs apart for investors.

Via The Motley Fool

Topics ETFs

SCHA Offers Larger Size and More Liquidity Than ISCB ↗

March 16, 2026

Via The Motley Fool

Topics ETFs

Trump Clears Path For Sable To Restart California Operations Amid Ongoing Iran War ↗

March 13, 2026

Energy Secretary Chris Wright directed Sable Offshore Corp. to begin restoring operations for the Santa Ynez Unit and Santa Ynez Pipeline System in California, Bloomberg News report said.

Via Stocktwits

Topics Government Lawsuit

Small-Cap ETFs: SCHA Owns the Whole Neighborhood, IJR Checks the Financials First ↗

March 12, 2026

Expense ratios, sector tilts, and stock counts set these two small-cap ETFs apart—see how their differences may impact your portfolio.

Via The Motley Fool

Topics ETFs

Rumble Stock Is Diving After Hours – What Happened To Q4 Revenue? ↗

March 05, 2026

The decline in Q4 revenue was attributable to a decrease in Audience Monetization revenues and lower Other Initiatives revenues. The revenue was in line with analyst expectations, per Fiscal.ai.

Via Stocktwits

Small Cap Stock Plug Power Rallies, Retail Cheers Q4 Earnings, New CEO Appointment ↗

March 02, 2026

The company said that Jose Luis Crespo will assume the role of Chief Executive Officer effective March 2, 2026.

Via Stocktwits

Red Cat Stock Surges On US-Israel-Iran War ↗

March 02, 2026

The U.S. and Israel’s attack on Iran over the weekend, and retaliatory strikes by Iran in the Gulf region has put defense-related stocks in focus, with several rallying in anticipation that the war is...

Via Stocktwits

Topics Government

Why Did QURE Stock Almost Halve Pre-Market Today? ↗

March 02, 2026

uniQure said the FDA does not agree that Phase I/II data are sufficient to serve as primary evidence of effectiveness for a marketing application for its Huntington’s disease gene therapy, AMT-130.

Via Stocktwits

UWM Holdings Stock Plunges 12% — Analyst Says Company Caught Shareholders ‘Off-Guard’ ↗

February 25, 2026

Several analysts were left surprised after UWM did not allow the question and answer session during its quarterly earnings call with analysts.

Via Stocktwits

Topics Earnings

Terawulf Stock Is Up 10% But Retail Still Sees More Than 250% Upside: Here’s Why ↗

February 24, 2026

Analysts expect the company to post higher fourth quarter revenue than the year-ago quarter, as per data from fiscal.ai.

Via Stocktwits

Topics Artificial Intelligence

Small-Cap Showdown: How Vanguard's VB Compares to Schwab's SCHA on Fees, Risk, and Diversification ↗

February 23, 2026

Explore how key differences in fees, sector focus, and risk profiles set these two small-cap ETFs apart for investors.

Via The Motley Fool

Topics ETFs

Want to Invest in Small-Cap Stocks? Check Out These Two Top ETFs ↗

February 22, 2026

Explore how sector focus, cost, and portfolio breadth set SCHA and SPSM apart for investors seeking tailored diversification.

Via The Motley Fool

Topics ETFs

Charles Schwab CEO Reportedly Explains Why AI Won’t Disrupt Wealth Management Industry: ‘We Are Able To Help A Whole New Group Of Clients’ ↗

February 11, 2026

CEO Rick Wurster said that AI should be viewed as a supportive tool rather than a replacement for human expertise, according to an interview with Bloomberg on Wednesday.

Via Stocktwits

Topics Artificial Intelligence

SCHA and VB Offer Similar Small-Cap ETF Advantages, but Which Is the Better Buy? ↗

February 09, 2026

Explore how subtle differences in cost, sector focus, and holdings could influence your small-cap ETF strategy.

Via The Motley Fool

Topics ETFs Stocks

Friedenthal Financial Buys $4.5 Million of First Trust Low Duration Opportunities ETF ↗

February 03, 2026

First Trust Low Duration Opportunities ETF targets income and capital preservation through active management of mortgage-related securities.

Via The Motley Fool

Topics ETFs Regulatory Compliance

Schwab vs. iShares: Is SCHA or IJR the Better U.S. Small-Cap ETF? ↗

January 13, 2026

Risk profiles, dividend yields, and stock selection set these two small-cap ETFs apart in ways that matter for portfolio construction.

Via The Motley Fool

Topics ETFs Stocks

SCHA vs. SPSM: Which Small-Cap ETF Is the Better Choice for Investors? ↗

January 03, 2026

Explore how differences in diversification, risk, and income potential set these two small-cap ETFs apart for investors.

Via The Motley Fool

Topics ETFs Stocks

DFA Breaks Vanguard's 20-Year Grip As SEC Approves ETF Share Classes ↗

November 18, 2025

The SEC has approved DFA to launch ETF share classes, opening the door for low-cost, tax-efficient ETF options, a structure long dominated by Vanguard.

Via Benzinga

Topics ETFs Regulatory Compliance

Neumora Therapeutics’ Experimental Drug Demonstrates Weight Loss in Preclinical Studies ↗

October 27, 2025

Neumora said that NMRA-215 demonstrated weight loss of up to 19% as a monotherapy and 26% in combination with Semaglutide.

Via Stocktwits

Alto Neuroscience Stock Soars After FDA Grants Fast Track Designation To Schizophrenia Drug ↗

October 03, 2025

FDA’s Fast Track designation is designed to facilitate the development and expedite the review of drugs intended to treat serious conditions and fill an unmet medical need.

Via Stocktwits

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.